(PGNX, MAKO, SKX) CRWENewswire Stocks In Action
Progenics Pharmaceuticals Incorporated - symbol PGNX - reported Net income for the second quarter 2011 of $55.5 million compared to a net loss of $15.2 million in the same period the prior year. Second quarter U.S. sales of Progenics’ RELISTOR increased 99% over first quarter and 50% over prior year quarter. MAKO Surgical Corporation - symbol MAKO - posted Second quarter 2011 revenue of $18.6 million, an 81% increase year over year.
09 Aug 2011